Durability of the deltamethrin-treated polypropylene long-lasting net LifeNet® in a pyrethroid resistance area in south western Benin: A phase III trial.

Armel DjènontinDaleb AlfaAziz BouraimaChristophe SoaresAmal DahountoSylvie CornélieMarc EgrotGeorgia DamienFranck RemouéAndré Barembaye SagnaNicolas MoirouxCédric Pennetier

Published in: PloS one (2023)

LifeNet® LLINs did meet WHO criteria for bio-efficacy throughout the study period and were well accepted by the population. This is an important step towards getting a full WHO recommendation for use in malaria endemic countries.

Keyphrases

phase iii
open label
clinical trial
phase ii
double blind
placebo controlled
aedes aegypti
south africa
study protocol
plasmodium falciparum
newly diagnosed